UDP-glucose is uridine diphosphoglucose. Steps in the process are catalyzed by: 1. hexokinase/glucokinase, 2. glucose-6-phosphatase (G6Pase), 3. phosphoglucomutase, 4. glycogen synthase, 5. branching enzyme, 6. glycogen phosphorylase, and 7. debranching enzyme (figure as modified from references 7 and 8). In glycogen storage disease type Ia there is a block in the conversion of glucose-6-phosphate to glucose due to a deficiency of glucose-6-phosphatase. This block results in markedly enhanced conversion of glucose-6-phosphate to: 1) to pyruvate and lactate; 2) to pyruvate and then to acetyl-CoA, fatty acids and finally to triglycerides; 3) to ribose-5-phosphate and then to uric acid; or to 4) to glucose-1-phosphate, then to UDP-glucose, then to amylopectin, and then to glycogen. The excess production of lactate, triglycerides, uric acid, and glycogen can be diminished by the administration of exogenous cornstarch (glucose polymer) on a regular and prescribed basis.